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Introduction 
Chrozophora prostrate (C. prostrata), Dalz. (Family; 
Euphorbiaceae) is locally known as Nilkanthi (Caius, 
1986). It grows in water logged areas and river banks as 
well as the dried areas of Pakistan (Caius, 1986; Nasir 
and Ali, 1986). It is known to be rich in 
leucoanthocyanidin, flavonoid and coumarin 
derivatives. Two xanthone glycosides i.e., 3,5,6,7,8-
pentamethoxyzanthone-1-O-rhamnosyl (1→6) 
glucopyranoside and 3,5,8-trimethoxyxanthone-1-O-
glucopyranoside as well as a chromone glycoside i.e., 2-
acetonyl-5-methyl-7-hydroxy-6-C-glucopyranosyl 
chromone-2”-O-glucopyranoside have been identified 
from the roots of C. prostrata (Agrawal and Singh, 1988). 
Different parts of the plant have extensively been used 
in the native system of medicine to treat various kinds 
of ailments. The leaves are presumed to possess 
depurative properties (Evan, 2002) and the seeds are 
known to possess laxative and alterative properties 
(Nadkarni, 1976). Ash of the root is used to manage 
cough in children (Kritkar and Basu, 1975). Decoction 
made from the plant has been employed to control 
leprous affections (Said, 1972). It is also regarded as 
blood purifier and used for the treatment of chronic 
persistent fever, syphilis, gonorrhea as well as 
leucoderma (Awan, 1993). 
The present study was undertaken to evaluate the 
folkloric repute laxative activity of C. Prostrata to 
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Abstract 
This study was undertaken to validate the medicinal use of Chrozophora 
prostrata in constipation. The crude extract of C prostrata produced laxative 
effect in mice at 100 and 300 mg/kg, similar to carbachol and castor oil. In 
spontaneously contracting rabbit jejunum tissues, C. prostrata (0.01-3 mg/mL) 
exhibited atropine-sensitive spasmogenic effect, which was reproducible in 
guinea-pig ileum. Interestingly, at high concentrations, C. prostrata showed 
concentration-dependent inhibitory effect on rabbit jejunum, suggesting the 
presence of accompanied spasmolytic activity. When tested on induced 
contractions, C. prostrata completely relaxed low K+-induced contraction, while 
partially inhibited high K+, similar to cromakalim. Tetraethylammonium 
pretreatment abolished the relaxant effect of C. prostrata on low K+-induced 
contractions while glibenclamide caused partial inhibition, suggesting the 
involvement of some non-specific and ATP-dependent K+ channels. These 
data show that C. prostrata possesses laxative effect at low doses mediated 
through cholinergic action followed by the spasmolytic activity at high doses 
mediated possibly through K+ channel activation.  
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rationalize its medicinal use by using both the in vitro 
and in vivo models. 
 
Materials and Methods 
Plant material and the extraction procedure: The dried 
plant material was purchased from a local herbal store 
in Multan, Pakistan and was identified by a taxonomist, 
Ms Saima Shehzadi, of the Institute of Pure and 
Applied Biology, Bahauddin Zakariya University, 
Multan. A specimen of the plant has been deposited at 
Herbarium at the Department of Biological and 
Biomedical Sciences Aga Khan University, Karachi, 
against voucher number Cp. A. 06-08-119. The herbal 
material was rendered free of any adulterant through 
manual picking and was ground to a coarse powder by 
an electrical grinder. Approximately 1 kg coarsely 
powdered plant material was soaked in the 80% 
aqueous-ethanol for one week with occasional shaking. 
It was passed through a double layer of muslin cloth 
and the obtained fluid was subsequently filtered 
through a Whatman grade 1 filter paper. The collected 
filtrate was concentrated on rotary evaporator (R-210, 
BUCHI, Switzerland) under reduced pressure at 37ºC to 
a thick, semi- solid mass, i.e., the crude ethanolic extract 
with the approximate yield of 8.3%. 
Animals: Rabbits and mice of local breed and either sex 
were used in the experiments and were kept at the 
animal house of Aga Khan University, Karachi, at 23-
25°C. Animals were provided with standard diet and 
tap water ad libitum but were subjected to 24 hours 
starvation prior to the experiments. Rabbits were 
sacrificed by a blow on the back of head for the in vitro 
experiments on gut tissues, while mice were used for 
the in vivo laxative study and acute toxicity testing. The 
animals were used in line with the guidelines of the 
Institute of Laboratory Animal Resources, Commission 
on Life Sciences, National Research Council (NRC, 
1996). 
Chemicals: The following chemicals were obtained from 
the sources specified: Acetylcholine chloride, atropine 
sulfate, potassium chloride, carbachol, cromakalim, 
glibenclamide, and tetra-ethyl ammonium chloride 
(TEA) from Sigma Chemicals Co. St Louis, MO, USA. 
Calcium chloride, glucose, magnesium chloride, 
sodium bicarbonate, sodium dihydrogen phosphate, 
hydrochloric acid, ethanol, acetic anhydride, ether, 
benzene and chloroform from Merck, Darmstadt, 
Germany, while sodium chloride, sodium hydroxide 
and ammonium hydroxide from BDH Laboratory 
supplies, Poole, England. All chemicals used in these 
experiments were of the highest purity and research 
grade. Stock solutions of all chemicals were prepared in 
normal saline, except cromakalim and glibenclamide 
which were dissolved in 10% DMSO (Di-methyl 
sulfoxide) and the volume made up by normal saline. 
The vehicle used for solubilization of drugs had no 
effect on tissue contractility in the control experiments. 
The stock solutions and their dilutions were made fresh 
on the day of experiment.  
In vivo experiments: Mice were used as the in vivo animal 
models for the evaluation of laxative activity in test 
materials in comparison to castor oil and carbachol as 
standard diarrhea inducers. Mice were deprived of food 
for 24 hours prior to the experiment but had free access 
to water. Twenty five animals were divided into five 
groups, each containing five mice. Each mouse was 
kept in a separate cage over a blotting sheet for 
convenience in fecal counting. Group1st animals, 
considered as the negative control, were treated orally 
with normal saline (10 mL/kg), group 2nd and 3rd, the 
positive controls, with castor oil (10 mL/kg) and 
carbachol (2 mg/kg), respectively, while the animal of 
group 4th and group 5th, labeled as the test groups, 
received oral doses of 100 and 300 mg/Kg of C. prostrata 
respectively. Total number of feces was counted for 
each mouse separately and calculated the average 
number of feces for each group. 
In vitro experiments: The effect of C. prostrata on gut 
motility was studied in isolated rabbit jejunum and 
guinea-pig ileum preparations as described previously 
(Shah et al., 2011). Approximately 2 cm long segments 
of jejunum or ileum were suspended in tissue baths 
containing Tyrode’s solution maintained at 37°C and 
aerated with carbogen (95% O2 and 5% CO2). Intestinal 
responses were recorded isotonically using Bioscience 
transducers attached to an Oscillograph and Powerlab 
Data Acquisition System (AD Instruments, Sydney, 
Australia) linked to a computer installed with Labchart 
software (version 6). The tissues were allowed to 
equilibrate for 30 min prior to addition of any chemical 
substance. The tissues were stabilized following 
repeated exposure to acetylcholine (0.3 μM) after 
washing with the Tyrode’s solution until the sub-
maximal responses of uniform amplitude were 
obtained. The observed modulation of spontaneous 
rhythmic contractions was used to test spasmolytic or 
spasmogenic activity in spontaneously contracting 
isolated rabbit jejunum preparation, whereas, induction 
of contraction with test or control drugs above that of 
the basal tone was used to measure spasmogenic 
activity in guinea-pig ileum. 
Acute toxicity testing: Mice were used for assessment of 
the acute toxicity. The animals were fasted 24 hours 
prior to experimentation but allowed free access to 
water. Twenty mice were divided into four groups each 
containing five animals. Group 1 was given normal 
saline (0.9% sodium chloride) orally and considered as 
the control group. Group 2, 3 and 4 were orally 
administered with 3, 5 and 7 g/Kg of C. prostrata, 
respectively. All the groups were observed for 24 hours 
for possible lethargy and mortality. 
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Statistical analysis: The data are expressed as the mean ± 
standard error of the mean (S.E.M.) and the median 
effective concentrations (EC50 values) with 95% 
confidence intervals (CI). The statistical test applied is 
the Student’s t-test and p<0.05 is considered as 
significantly different. 
 
Results 
Oral administration of castor oil (10 mL/kg) and 
carbachol (2 mg/kg) to mice resulted in significant 
laxative effect with mean fecal count of 10.60 ± 2.04 and 
10.20 ± 0.58, respectively, as compared to 5.2 ± 1.48 with 
saline. In the test groups, treatment with 100 and 300 
mg/kg C. prostrata exhibited dose-dependent laxative 
effect with respective mean fecal count of 8.20 ± 1.02 
and 13.40 ± 2.54 (Figure 1). 
Application of C. prostrata on spontaneously contracting 
rabbit jejunum exhibited biphasic response i.e., initial 
concentration-dependant (0.01-0.3 mg/mL) excitation 
followed by the concentration-dependant inhibition of 
the spontaneous contractions (1-3 mg/mL). The 
spasmogenic effect of C. prostrata was suppressed by 
pretreatment of the tissues with 0.1 μM atropine (Figure 
2a). C. prostrata caused relaxation of low K+ (25 mM)-
induced contractions with EC50 value of 0.22 mg/mL 
(0.16-0.31, 95% CI) whereas, it caused partial relaxation 
of high K+ (80 mM)-induced contractions, similar to 
cromakalim (Figure 2a and b). When applied on guinea
-pig ileum, C. prostrata caused contractions in a 
concentration-dependent manner. The respective 
contractions at 0.3, 1, 3 and 10 mg/mL were recorded as 
7.67 ± 1.45, 15.00 ± 2.89, 34.67 ± 2.91 and 54.67% ± 4.67 
of the ACh-induced maximum response (Figure 3). Pre-
incubation of the tissue with atropine 0.1 µM abolished 
the spasmogenic effect of C. prostrata, like that of 
acetylcholine. 
The inhibitory effect of C. prostrata was blocked in the 
tissues pretreated with TEA (10 mM) while partially 
reversed in the glibenclamide (30 μM) pretreated 
preparations. The inhibitory effect of cromakalim on 
low K+-induced contractions was completely inhibited 
in the tissue pretreated with glibenclamide (Figure 4a 
and b).  
Figure 1: Comparative laxative effect of 100 mg/Kg and 300 mg/kg crude extract of C. prostrata , castor oil (10 ) and carbachol (2 
mg/Kg) against normal saline (10 mL/kg) in healthy mice. *p < 0.05, **p<0.01 vs. Saline group. 
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The oral dose of C. prostrata as high as 7 mg/ Kg, did 
not produce lethality among the treated groups of mice. 
 
Discussion 
C. prostrata was subjected to pharmacological 
investigation in order to validate its folkloric repute in 
constipation (Nadkarni, 1976). When studied for its 
laxative effect in mice, C. prostrata enhanced fecal 
production similar to CCh. To study the possible mode 
of action of its laxative activity, the aqueous ethanolic 
plant extract was tested on spontaneously contracting 
rabbit jejunum preparations, where it produced 
atropine-sensitive spasmogenic effect at lower 
concentrations, indicating possible presence of gut 
stimulatory component(s). The spasmogenic effect of C. 
prostrata was further studied on guinea-pig ileum, a 
quiescent preparation considered useful for this 
purpose (Bashir et al., 2006). The plant extract produced 
contractions in ileum preparations which were also 
blocked in the presence of atropine, thus confirming the 
presence of spasmogenic effect in C. prostrata mediated 
possibly through stimulation of cholinergic receptors, 
similar to ACh, which is known to have excitatory 
action on gut segments (Brown and Taylor, 2006). The 
spasmodic effect observed at low concentrations in 
rabbit jejunum was moderate when compared with 
ACh-induced maximum contractions.  
Interestingly at higher concentrations, C. prostrata failed 
to produce spasmogenic effect and showed dose-
dependent spasmolytic activity which is perhaps meant 
by nature to offset the excessive stimulation of gut 
motility which could be harmful through causing 
abdominal cramps, as seen with chemical drugs used as 
laxative (Pasricha, 2008). The observed spasmolytic 
effect of the plant extract when investigated for possible 
mechanisms, it showed selective inhibition of low K+-
induced contractions while a weak inhibitory influence 
was observed against high K+. As the plant extract was 
Figure 2: Effect of crude extract of C. prostrata on spontaneous, atropine (0.1 µM) incubated spontaneous, K+ (80 mM) and K+ (25 
mM)-induced contractions (a) and that of cromakalim on spontaneous, K+ (80 mM) and K+ (25 mM) induced contractions (b) in 
isolated rabbit jejunum preparations (values expressed are mean ± S.E.M. for n = 5). 
Figure 3: Concentration-dependent spasmogenic effect of crude 
extract of C. prostrata in the absence and presence of atropine 
(0.1 µM) in isolated guinea-pig ileum. The responses are given 
as % of acetylcholine (10 µM) induced maximum contraction 
(ACh Max.). The values are shown as mean ± SEM, n = 4.  
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capable to cause complete relaxation of low K+-induced 
spastic contractions, hence, it can be speculated that 
some of the plant components may possibly exert their 
effect through opening of K+ channels (Hamilton et al., 
1986; Kishii et al., 1992; Khan et al., 2011). K+ channel 
openers produce smooth muscle relaxation via 
decreased intracellular free Ca+2 mediated by hyper-
polarization of membrane through increased K+ efflux 
on opening of K+ channels (Quest and Cook, 1989; 
Weston and Edwards, 1992). 
To know the nature of K+-channels involved in the 
antispasmodic effect of the plant extract, its relaxant 
effect against low K+ was reproduced in the presence of 
TEA, a nonspecific K+-channel blocker (Wu et al., 2004) 
and glibenclamide, an ATP-dependent K+-channel 
blocker (Frank et al., 1994). TEA completely inhibited 
the inhibitory effect of C. Prostrata, while glibenclamide 
showed partial inhibition, showing the predominant 
involvement of non-specific K+-channel activation and 
the partial involvement of the specific ATP-dependent 
K+-channels. On the other hand, the inhibitory effect of 
cromakalim, a specific ATP-dependent K+-channel 
opener (Escande et al., 1988), was completely inhibited 
when studied in tissues pretreated with glibenclamide.  
C. prostrata was found safe in mice up to the dose of as 
high as 7 g/kg indicating that it is relatively safe for 
short term use, though further chronic toxicity testing is 
required to know the true safety profile. 
These data indicate that C. prostrata possesses laxative 
and gut stimulant properties possibly mediated 
through cholinergic receptor stimulation. However, the 
accompanied spasmolytic effect observed at high doses 
was found mediated through non-specific and ATP-
sensitive K+-channel activation and was perhaps meant 
by nature to offset the excessive stimulation which 
could have been harmful. 
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